ACS |
acute coronary syndrome |
ADH |
antidiuretic hormone |
ADM |
adrenomedullin |
AMI |
acute myocardial infarction |
ANP |
atrial natriuretic peptide |
AVP |
arginine vasopressin |
BNP |
B-type natriuretic peptide |
BSA |
bovine serum albumin |
CHD |
coronary heart disease |
CHF |
congestive heart failure |
CK |
creatine phosphokinase |
CRP |
C-reactive protein |
cTnI |
cardiac troponin I |
cTnT |
cardiac troponin T |
CV |
cyclic voltammetry |
CVDs |
cardiovascular diseases |
DNA |
deoxyribonucleic acid |
DPV |
differential pulse voltammetric |
EIS |
electrochemical impedance spectroscopy |
ELISA |
enzyme-linked immunosorbent assay |
ELONA |
enzyme-linked oligonucleotide assay |
FET |
field-effect transistor |
FICA |
fluorescence immunochromatographic assay |
GDF15 |
growth differentiation factor 15 |
GDF8 |
growth differentiation factor 8, myostatin |
HF |
heart failure |
hFABP |
heart-type fatty acid-binding protein |
HSA |
human serum albumin |
IgE |
immunoglobulin E |
IL-6 |
interleukin-6 |
LOD |
limit of detection |
MR-proADM |
mid-region-proADM |
Nt |
nucleotides |
NT-proBNP |
N-terminal proBNP |
POC |
point-of-care |
RNA |
ribonucleic acid |
SELEX |
systematic evolution of ligands by exponential enrichment |
SERS |
surface-enhanced Raman spectroscopy |
SOMAmer |
slow off-rate modified aptamers |
SPR |
surface plasmon resonance |
sST2 |
soluble suppression of tumorigenicity 2 |
ST2 |
suppression of tumorigenicity 2 |
ST2L |
transmembrane suppression of tumorigenicity 2 |
SWV |
square wave voltammetry |
TGF-β |
transforming growth factor-β |
TNFα |
tumor necrosis factor alpha |
WHO |
world health organization |